Esomeprazole | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Esomeprazole
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Granules Esomeprazole Magnesium

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Esomeprazole

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

137 API Suppliers, 65 USDMF, 48 CEP/COS, 7 JDMF, 37 EU WC, 79 KDMF, 45 NDC API, 66 Listed Suppliers, $ API Reference Price

137 API Suppliers
65 USDMF
48 CEP/COS
7 JDMF
37 EU WC
79 KDMF
45 NDC API
66 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

14 Intermediates Suppliers

14 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

912 FDF Dossiers, 92 FDA Orange Book, 464 Europe, 23 Canada, 86 Australia, 62 South Africa, 185 Listed Dossiers

912 FDF Dossiers
92 FDA Orange Book
464 Europe
23 Canada
86 Australia
62 South Africa
185 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 1 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 8 DKSH, 3 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 15 Corel Pharma Chem, 3 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 11 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 19 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 69 Coating Systems & Additives, 43 Controlled & Modified Release, 38 Direct Compression, 32 Thickeners and Stabilizers, 30 Solubilizers, 26 Taste Masking, 25 Granulation, 24 Disintegrants & Superdisintegrants, 21 Lubricants & Glidants, 20 Co-Processed Excipients, 18 Film Formers & Plasticizers, 17 Chewable & Orodispersible Aids, 16 Topical, 16 Parenteral, 9 Emulsifying Agents, 9 Empty Capsules, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Rheology Modifiers

71 Fillers, Diluents & Binders
69 Coating Systems & Additives
43 Controlled & Modified Release
38 Direct Compression
32 Thickeners and Stabilizers
30 Solubilizers
26 Taste Masking
25 Granulation
24 Disintegrants & Superdisintegrants
21 Lubricants & Glidants
20 Co-Processed Excipients
18 Film Formers & Plasticizers
17 Chewable & Orodispersible Aids
16 Topical
16 Parenteral
9 Emulsifying Agents
9 Empty Capsules
6 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 Rheology Modifiers

DIGITAL CONTENT

16 DATA COMPILATION #PharmaFlow, 152 NEWS #PharmaBuzz

16 DATA COMPILATION #PharmaFlow
152 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 395 Finished Drug Prices, 16 Annual Reports

3 US Medicaid Prescriptions
395 Finished Drug Prices
16 Annual Reports

MARKET PLACE

67 APIs, 35 FDF Dossiers

67 APIs
35 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 44 Health Canada Patents

2 US Patents
44 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 1 USP, 21 Others

5 EDQM
1 USP
21 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 204 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2DEXCEL

filter Patent Number Reset all filters

2 All

01 110076494

02 110835488

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22036-12-08

Esomeprazole Magnesium

Product Main Page

01

DEXCEL

ESOMEPRAZOLE MAGNESIUM

Compamed

Not Confirmed

DEXCEL

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-12-08

ESOMEPRAZOLE MAGNESIUM

US Patent Number : 10076494

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214278

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-12-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

DEXCEL

ESOMEPRAZOLE MAGNESIUM

Compamed

Not Confirmed

DEXCEL

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-12-08

ESOMEPRAZOLE MAGNESIUM

US Patent Number : 10835488

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214278

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-12-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?